Not only does psoriasis take a huge physical toll, often undiscussed are the mental effects the skin disease has in people’s lives. Almirall hopes to change this with its "Shedding Light on Psoriasis" ...
Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis. Half of ...
Otezla (apremilast) and methotrexate are two common options for treating moderate to severe psoriasis and psoriatic arthritis, with clear differences in how they work, side effects, and how they fit ...
The National Psoriasis Foundation has issued a detailed primer supporting GLP-1 receptor agonists as an adjunct therapy for psoriasis in patients with metabolic comorbidities. Evidence shows these ...
F rom topicals and light therapy to systemic medications, a variety of treatments are available to treat psoriasis. Because each option is unique, some will work better for you than others. A ...
MedPage Today on MSN
NPF Primer: GLP-1s Worth Considering as Adjunct for Select Psoriasis Patients
Mounting evidence of improved outcomes as add-on to psoriasis drugs in patients with obesi ...
A therapy that works similarly to AbbVie’s blockbuster Skyrizi appeared more potent in a mid-stage trial and has the ...
Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream. The researchers, whose study is published ...
Creams play an important role in the treatment of plaque psoriasis to help improve the appearance of the skin and reduce itching. New medicines that target the underlying inflammation caused by plaque ...
Biologic medications are drugs that target specific parts of your immune system to treat disease. If you have a condition like psoriatic arthritis, biologics can make a big difference. They can ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results